Granix and Ibrance drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Granix (tbo-filgrastim) and Ibrance (palbociclib). Common drug interactions include white blood cell count decreased among females.

The phase IV clinical study analyzes what interactions people have when they take Granix and Ibrance. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Granix?

Granix has active ingredients of tbo-filgrastim. eHealthMe is studying from 897 Granix users. Check the latest studies of Granix.

What is Ibrance?

Ibrance has active ingredients of palbociclib. eHealthMe is studying from 104,434 Ibrance users. Check the latest studies of Ibrance.

On Jul, 19, 2026

45 people who take Granix and Ibrance together, and have interactions are studied.

What are the common drug interactions of Granix and Ibrance, by gender? *:

female:

White blood cell count decreased
Alopecia (absence of hair from areas of the body)
White blood cell disorder
Neutropenia (an abnormally low number of neutrophils)
Dry skin
Ear disorder
Ear pain
Hypermagnesaemia (an electrolyte disturbance in which there is an abnormally elevated level of magnesium in the blood)
Joint injury
Joint swelling

male:

n/a

What are the common drug interactions of Granix and Ibrance, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Disease progression
Alopecia (absence of hair from areas of the body)
Fatigue (feeling of tiredness)
Fibromyalgia (a long-term condition which causes pain all over the body)
Visual impairment
Breast cancer
Device related infection
Hot flush (sudden feelings of heat)
Nasopharyngitis (inflammation of the nasopharynx)
Neoplasm progression (growth of tumour)

50-59:

Neoplasm progression (growth of tumour)
Neutropenia (an abnormally low number of neutrophils)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Sepsis (a severe blood infection that can lead to organ failure and death)
Urinary tract infection
Vomiting
Headache (pain in head)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Arthralgia (joint pain)
Diarrhoea

60+:

White blood cell count decreased
Alopecia (absence of hair from areas of the body)
Ear disorder
Ear pain
Headache (pain in head)
Hypermagnesaemia (an electrolyte disturbance in which there is an abnormally elevated level of magnesium in the blood)
Joint injury
Joint swelling
Lymphoedema (localized fluid retention and tissue swelling)
Neutropenia (an abnormally low number of neutrophils)

What are the existing conditions these people have? *

Breast Cancer Female: 20 people, 44.44%
Breast Cancer: 12 people, 26.67%
Breast Cancer Metastatic: 9 people, 20.00%
Metastases To Bone (cancer spreads to bone): 8 people, 17.78%
White Blood Cell Count Decreased: 3 people, 6.67%
Magnesium Deficiency (lack of magnesium): 3 people, 6.67%
Blood Potassium Decreased: 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Granix and Ibrance?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously